- TWD9.60bn
- TWD9.06bn
- TWD2.62bn
- 61
- 20
- 92
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,424 | 2,414 | 2,813 | 2,940 | 2,617 |
Cost of Revenue | |||||
Gross Profit | 348 | 407 | 601 | 935 | 930 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,444 | 2,386 | 2,632 | 2,650 | 2,391 |
Operating Profit | -19.5 | 27.3 | 181 | 290 | 226 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.21 | -45.7 | 151 | 426 | 248 |
Provision for Income Taxes | |||||
Net Income After Taxes | -19.3 | -38.1 | 103 | 322 | 168 |
Net Income Before Extraordinary Items | |||||
Net Income | -19.3 | -38.1 | 103 | 322 | 168 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -19.3 | -38.1 | 103 | 322 | 168 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.271 | -0.513 | 1.53 | 4.72 | 2.48 |
Dividends per Share |